John Barnhart - Net Worth and Insider Trading

John Barnhart Net Worth

The estimated net worth of John Barnhart is at least $479 dollars as of 2024-11-13. John Barnhart is the Director of Atossa Therapeutics Inc and owns about 319 shares of Atossa Therapeutics Inc (ATOS) stock worth over $479. Details can be seen in John Barnhart's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Barnhart has not made any transactions after 2012-11-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John Barnhart

To

John Barnhart Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Barnhart owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .

Click here to see the complete history of John Barnhart’s form 4 insider trades.

Insider Ownership Summary of John Barnhart

Ticker Comapny Transaction Date Type of Owner
ATOS Atossa Therapeutics Inc 2012-11-07 director

John Barnhart Latest Holdings Summary

John Barnhart currently owns a total of 1 stock. John Barnhart owns 319 shares of Atossa Therapeutics Inc (ATOS) as of November 7, 2012, with a value of $479.

Latest Holdings of John Barnhart

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATOS Atossa Therapeutics Inc 2012-11-07 319 1.50 479

Holding Weightings of John Barnhart


John Barnhart Form 4 Trading Tracker

According to the SEC Form 4 filings, John Barnhart has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the sale of 0 shares on November 7, 2012, which brought John Barnhart around $0.

Insider Trading History of John Barnhart

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Barnhart Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Barnhart Ownership Network

Ownership Network List of John Barnhart

No Data

Ownership Network Relation of John Barnhart

Insider Network Chart

John Barnhart Owned Company Details

What does Atossa Therapeutics Inc do?

Who are the key executives at Atossa Therapeutics Inc?

John Barnhart is the director of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .

Atossa Therapeutics Inc (ATOS) Insider Trades Summary

Over the past 18 months, John Barnhart made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .

In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.

Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atossa Therapeutics Inc Insider Transactions

No Available Data

John Barnhart Mailing Address

Above is the net worth, insider trading, and ownership report for John Barnhart. You might contact John Barnhart via mailing address: C/o Atossa Genetics, Inc, 4105 E Madison Street, Suite 320, Seattle Wa 98112.